Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LINQUAL-ORAL TRAINING SPLINT

K-Number: K813603 · 1982-01-26

Decision Date1982-01-26
Product Code
DecisionSubstantially Equivalent

Device Summary

LINQUAL-ORAL TRAINING SPLINT is the device name listed in this FDA 510(k) record. The listed applicant is Charles F. Samelson, M.D.. It received FDA 510(k) clearance on 1982-01-26 under 510(k) number K813603. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LINQUAL-ORAL TRAINING SPLINT?

LINQUAL-ORAL TRAINING SPLINT is a medical device that received FDA 510(k) clearance on 1982-01-26. The listed applicant is Charles F. Samelson, M.D.. The 510(k) number is K813603.

When did LINQUAL-ORAL TRAINING SPLINT receive FDA 510(k) clearance?

LINQUAL-ORAL TRAINING SPLINT received FDA 510(k) clearance on 1982-01-26, under 510(k) number K813603.

Who is the listed applicant for LINQUAL-ORAL TRAINING SPLINT?

The FDA 510(k) record lists Charles F. Samelson, M.D. as the applicant. This does not by itself establish the device manufacturer.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑